Novogene Co., Ltd.

¥18.58As of Sun 8 Nov 2026, 12:00 UTC
SSE:688315Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (13.93%)
Div yield 0.24%
ROE 5.78%
Biotechnology
Beta (5Y) 0.76
PE TTM 50.13
TSR TTM 27.44%
Mkt cap ¥7.526B
ROIC 13.07%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
2.62%
(54.35%)
Hold 6|12|7|6|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.27
0.30
0.30
0.30
14.44%
27.08%
20.75%
22.14%
Revenue¥M
375.6
370.1
364.3
385.8
13.60%
8.49%
1.23%
3.89%
Peers (US$1.128B)
Cap (US$)
PE
1.109B
18.76x
1.124B
34.63x
Capital
TTM
5Y
10Y
Leveragex
1.946
0.578
0.535
EBIT/Intx
2.386
0.133
0.126
Own earn%
(30.01)
32.29
35.22
Sh yield%
43.05
31.33
32.63
Owners
Insiders/Inst%
2.03
31.40
Short interest%
3.47
SBC / revenue%
4.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
25–31
$1 testx
—
Incr. ROIC%
3